← FDA Drug Approvals (Drugs@FDA)

DACARBAZINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: FRESENIUS KABI USA · Approved 1999-08-27

Drug application

FDA Application #
ANDA075371
Application type
Abbreviated New Drug Application (Generic)
Brand name
DACARBAZINE
Generic name
DACARBAZINE
Active ingredients
DACARBAZINE
Dosage form
INJECTABLE
Route
INJECTION
Marketing status
Prescription
Sponsor
FRESENIUS KABI USA
Manufacturer
Fresenius Kabi USA, LLC
First approval
1999-08-27

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown